Marc N Potenza Selected Research

Marc N Potenza Research Topics

Disease

50	Gambling (Pathological Gambling) 04/2024 - 01/2003
26	Substance-Related Disorders (Drug Abuse) 04/2024 - 01/2009
14	Cocaine-Related Disorders (Cocaine Addiction) 01/2019 - 03/2006
11	Alcoholism (Alcohol Abuse) 04/2024 - 11/2008
9	Disruptive, Impulse Control, and Conduct Disorders (Kleptomania) 05/2013 - 07/2006
8	Obesity 01/2022 - 02/2010
8	Parkinson Disease (Parkinson's Disease) 03/2016 - 07/2006
5	Mental Disorders (Mental Disorder) 01/2023 - 03/2004
5	COVID-19 01/2021 - 01/2020
5	Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder) 12/2020 - 01/2009
4	Tobacco Use Disorder (Nicotine Dependence) 01/2024 - 11/2013
4	Food Addiction 12/2023 - 04/2015
4	Wounds and Injuries (Trauma) 12/2020 - 08/2014
3	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 01/2024 - 06/2020
3	Mood Disorders (Mood Disorder) 01/2023 - 07/2019
3	Pain (Aches) 01/2021 - 01/2017
2	Opioid-Related Disorders (Opiate Addiction) 08/2023 - 01/2022
2	Anxiety Disorders (Anxiety Disorder) 05/2023 - 06/2014
2	Binge-Eating Disorder (Binge Eating Disorder) 02/2023 - 01/2021
2	Substance Withdrawal Syndrome (Withdrawal Symptoms) 01/2022 - 01/2019
2	Bulimia (Binge Eating) 04/2016 - 03/2014
1	Hypertension (High Blood Pressure) 03/2022
1	Heart Diseases (Heart Disease) 03/2022
1	Epilepsy (Aura) 01/2022
1	Multiple Sclerosis 01/2022
1	Major Depressive Disorder (Major Depressive Disorders) 09/2021
1	Genetic Risk Score 01/2021
1	Marijuana Use 12/2020
1	Medically Unexplained Symptoms 11/2020
1	Disease Progression 10/2017

Drug/Important Bio-Agent (IBA)

32	Cocaine (Cocaine HCl)IBA 04/2024 - 10/2004
10	Dopamine (Intropin)FDA LinkGeneric 01/2021 - 12/2007
8	Neurotransmitter Agents (Neurotransmitter)IBA 01/2020 - 05/2008
8	Dopamine Agonists (Dopamine Agonist)IBA 03/2016 - 07/2006
5	Immunoglobulin D (IgD)IBA 02/2023 - 01/2017
5	Heroin (Diamorphine)IBA 12/2022 - 02/2010
5	CannabinoidsIBA 01/2022 - 12/2012
5	Narcotic Antagonists (Opioid Antagonists)IBA 02/2020 - 01/2003
5	Serotonin (5 Hydroxytryptamine)IBA 01/2020 - 01/2004
4	Methamphetamine (Desoxyn)FDA LinkGeneric 12/2023 - 03/2019
4	Methadone (Dolophine)FDA LinkGeneric 01/2021 - 09/2016
4	Opioid Analgesics (Opioids)IBA 01/2021 - 08/2013
4	Naltrexone (ReVia)FDA LinkGeneric 02/2020 - 11/2008
4	Nicotine FDA Link 01/2014 - 03/2009
3	Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA 05/2023 - 01/2003
3	Amphetamine (Amfetamine)FDA LinkGeneric 12/2022 - 11/2020
3	Illicit Drugs (Recreational Drugs)IBA 01/2021 - 11/2013
3	SmokeIBA 11/2020 - 06/2008
3	Paroxetine (Paxil)FDA LinkGeneric 09/2016 - 07/2003
3	nalmefene (Revex)FDA Link 10/2010 - 02/2006
2	Indicators and Reagents (Reagents)IBA 11/2023 - 09/2016
2	Norepinephrine (Noradrenaline)FDA LinkGeneric 05/2023 - 08/2013
2	Biomarkers (Surrogate Marker)IBA 02/2023 - 01/2018
2	Insulin (Novolin)FDA Link 03/2022 - 02/2013
2	amsonic acid (DAS)IBA 01/2020 - 03/2016
2	Crack CocaineIBA 03/2019 - 01/2009
2	Disulfiram (Antabuse)FDA Link 11/2017 - 01/2017
2	Opiate AlkaloidsIBA 01/2017 - 11/2008
2	Caffeine (No Doz)FDA LinkGeneric 12/2015 - 01/2014
2	CB1 Cannabinoid Receptor (CB1 Receptor)IBA 10/2014 - 12/2012
2	Norepinephrine Plasma Membrane Transport Proteins (Norepinephrine Transporter)IBA 02/2014 - 11/2013
2	Glutamic Acid (Glutamate)FDA Link 08/2013 - 12/2010
2	5-HT1B Serotonin ReceptorIBA 03/2013 - 05/2010
2	Antipsychotic Agents (Antipsychotics)IBA 01/2004 - 01/2003
1	N-(2-acetamido)-2-aminoethanesulfonic acid (ACES)IBA 04/2024
1	salicylhydroxamic acid (SHAM)IBA 01/2024
1	Hormones (Hormone)IBA 12/2023
1	LeptinIBA 12/2023
1	glyceryl 2-arachidonate (2-arachidonoylglycerol)IBA 11/2023
1	anandamide (arachidonylethanolamide)IBA 11/2023
1	mesoglycanIBA 06/2023
1	Serotonin and Noradrenaline Reuptake InhibitorsIBA 05/2023
1	OrexinsIBA 01/2023
1	NeuropeptidesIBA 01/2023
1	Glial Cell Line-Derived Neurotrophic Factor (GDNF)IBA 04/2022
1	Glycoproteins (Glycoprotein)IBA 01/2022
1	Baclofen FDA LinkGeneric 01/2022
1	Modafinil (Provigil)FDA Link 01/2022
1	Hallucinogens (Psychedelics)IBA 01/2022
1	Ketamine FDA LinkGeneric 01/2022
1	saracatinibIBA 01/2022
1	Phosphotransferases (Kinase)IBA 01/2022
1	Sodium Oxybate (gamma Hydroxybutyrate)FDA Link 01/2022
1	Dronabinol (THC)FDA LinkGeneric 01/2022
1	SuspensionsIBA 01/2021
1	COVID-19 VaccinesIBA 01/2021
1	gamma-Aminobutyric Acid (GABA)IBA 01/2021
1	naxagolideIBA 01/2021
1	4-amino-4'-hydroxylaminodiphenylsulfone (HADS)IBA 01/2021
1	N-Methyl-3,4-methylenedioxyamphetamine (MDMA)IBA 03/2019
1	BenzodiazepinesIBA 01/2019
1	SugarsIBA 01/2017
1	Oxytocin (Pitocin)FDA LinkGeneric 01/2017
1	CarbohydratesIBA 01/2017

Therapy/Procedure

15	Therapeutics 01/2021 - 12/2007
9	Drug Therapy (Chemotherapy) 05/2023 - 07/2006
2	Behavior Control 01/2024 - 02/2013
2	Duration of Therapy 01/2021 - 01/2003
2	Aftercare (After-Treatment) 01/2014 - 05/2012
1	Transcranial Direct Current Stimulation 01/2021